Google Alert - lose weight

	lose weight As-it-happens update ⋅ January 17, 2025
	NEWS
	STEP UP Trial Shows Semaglutide 7.2 mg Achieves Superior Weight Loss vs. 2.4 mg, Placebo Applied Clinical Trials STEP UP T2D is evaluating semaglutide 7.2 mg in 512 adult patients with obesity and type 2 diabetes. That trial's primary endpoint is to establish the ... Flag as irrelevant
	Nicotine pouches touted as 'Gen Z's favorite accidental weight loss drug' gets FDA approval Daily Mail Zyn nicotine pouches loved by young people for their appetite-suppressing effects have officially been approved in the US. Flag as irrelevant
See more results | Edit this alert

You have received this email because you have subscribed to Google Alerts. Unsubscribe | View all your alerts

Receive this alert as RSS feed

Send Feedback